ARMI - Advanced Regenerative Manufacturing Institute
ARMI´s mission is to make practical the scalable, consistent, cost-effective manufacturing of tissue engineered medical products and tissue related technologies, to benefit existing industries and grow new ones.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Nationally (across the country)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
ARMI's BioFabUSA program is designed to attract and develop an ecosystem of both large and small industrial/commercial institutions. Given the nascent stage of the regenerative manufacturing industry, this includes Tissue-Engineering and Regenerative Medicine (TERM) startup companies as well as larger firms that see this as an attractive adjacent market opportunity. Also included in this ecosystem are educational, medical and mission driven non-profit institutions whose areas of research, areas of practice or philanthropic mission include, or could benefit from, TERM or TERM related therapies or technologies. This includes organizations whose mission align with the prospect of developing TERM therapies to help cure certain diseases (e.g., diabetes, renal failure and limb loss) or advancing the tissue manufacturing industry (e.g., engineering/scientific societies and standards development organizations).
Our Mission
Significant breakthroughs in cell biology, biofabrication and materials science in the last decade have laid the foundation for scalable manufacturing and commercialization of engineered tissues and tissue-related technologies, including tissues- and organs-on-chip. However, the tissue engineering field is fragmented and lacks a mechanism with which to turn laboratory breakthroughs into manufactured products. Therefore, the nation needs an industrial commons, in the form of a Manufacturing Innovation Institute (MII) within the Manufacturing USA network, in which to coalesce the field and provide a route for nascent product concepts to reach the marketplace. Bringing these products to the market will benefit critical U.S. public health needs and will provide the economic drivers needed to create new highly-skilled jobs.
